Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDP733 in Irritable Bowel Syndrome with Constipation
NCT00215566Phase 2Completed
- Sponsor
- Dynogen Pharmaceuticals, Inc.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pumosetrag in irritable bowel syndrome (IBS), sponsored by Dynogen Pharmaceuticals, Inc.. Started Sep 2005; status: completed.
02
Drugs
pumosetrag
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00215566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00215566.